Results 61 to 70 of about 9,917 (88)

Oncogenic osteomalacia and metastatic breast cancer: a case report and review of the literature

Journal of Diabetes and Metabolic Disorders, 2019
C. Savva, J. Adhikaree, S. Madhusudan, K. Chokkalingam   +3 more
semanticscholar   +1 more source

Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases

Calcified Tissue International, 2022
Tumor-induced osteomalacia (TIO) is a rare and largely underdiagnosed paraneoplastic condition. Previous reviews often reported incomplete data on clinical aspects, diagnosis or prognosis. The aim of this study was to present a systematic clinical review
Ariadne Bosman
exaly   +2 more sources

Tumor-Induced Osteomalacia

Calcified Tissue International, 2020
Pablo Florenzano, Iris R Hartley, Michael T Collins   +2 more
exaly   +2 more sources

Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor‐Induced Osteomalacia: Outcome of a Retrospective Surveillance

Journal of Bone and Mineral Research, 2022
Tumor‐induced osteomalacia (TIO) is an acquired fibroblast growth factor 23 (FGF23)‐related hypophosphatemic osteomalacia caused by phosphaturic mesenchymal tumors (PMTs) developed in the bone or soft tissue.
Naoko Hidaka, M. Koga, S. Kimura, Yoshitomo Hoshino, H. Kato, Y. Kinoshita, N. Makita, M. Nangaku, Kazuhiko Horiguchi, Yasushi Furukawa, K. Ohnaka, K. Inagaki, A. Nakagawa, Atsushi Suzuki, Y. Takeuchi, S. Fukumoto, F. Nakatani, N. Ito   +17 more
semanticscholar   +1 more source

Tumour-induced osteomalacia

Nature Reviews Disease Primers, 2017
Salvatore Minisola, Seijii Fukumoto, Cristiana Cipriani   +2 more
exaly   +3 more sources

Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial

Journal of Bone and Mineral Research, 2019
In adults with X‐linked hypophosphatemia (XLH), excess FGF23 impairs renal phosphate reabsorption and suppresses production of 1,25‐dihydroxyvitamin D, resulting in chronic hypophosphatemia and persistent osteomalacia.
Karl L Insogna, Frank Rauch, Peter Kamenický   +2 more
exaly   +2 more sources

OSTEOMALÁCIA ONCOGÊNICA: UMA CONDIÇÃO SUBDIAGNOSTICADA, MAS DE GRANDE REPERCUSSÃO CLÍNICA.

BJN Abstract-CBN24
Apresentação de caso: Paciente feminina, previamente hígida, que aos 39 anos de idade começou a apresentar fraqueza muscular, dores ósseas e fez fratura espontânea no fêmur direito.
Larissa Lauzy Macedo Marques¹, Isabela Bertoncello², Izabela Veras dos Santos¹, Nicole Rampani Franzoni¹, Bruno dos Santos Oliveira², Sérgio Gardano Elias Bucharles¹   +5 more
semanticscholar   +1 more source

Nutritional Rickets and Osteomalacia in the Twenty-first Century: Revised Concepts, Public Health, and Prevention Strategies

Current Osteoporosis Reports, 2017
Purpose of ReviewNutritional rickets and osteomalacia are common in dark-skinned and migrant populations. Their global incidence is rising due to changing population demographics, failing prevention policies and missing implementation strategies.
S. Uday, W. Högler
exaly   +2 more sources

Osteomalácia oncogênica secundária a tumor mesenquimal fosfatúrico

Brazilian Radiological Cases, 2023
Paula Ferreira Possa, Luciana Costa Silva, Luciene Mota de Andrade, Marcelo Bordalo Rodrigues   +3 more
semanticscholar   +1 more source

Tumor-induced Osteomalacia due to a Phosphaturic Mesenchymal Tumor in the Cervical Spine: A Case Report and Literature Review

Neurology India, 2019
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome of certain mesenchymal tumors which secrete fibroblast growth factor-23 (FGF-23) responsible for causing features of hypophosphatemia and osteomalacia in these patients.
Nitish Agarwal, S. Kale, K. Kumari
semanticscholar   +1 more source